Alpha DNA Investment Management’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-927
Closed -$54K – 294
2021
Q1
$54K Hold
927
– – 0.06% 160
2020
Q4
$53K Buy
+927
New +$51.2K 0.06% 173

Other funds holding FHLC

Alpha DNA Investment Management's FHLC Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Fidelity MSCI Health Care Index ETF (FHLC) in Q2 2021, closing a stake of 927 shares — an estimated $54K sold.

Alpha DNA Investment Management first reported a position in FHLC in Q4 2020 and held it in 2 quarters. The position peaked at $54K in Q1 2021. 236 funds tracked by Wall St. Rank hold FHLC as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Fidelity MSCI Health Care Index ETF position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 927 Fidelity MSCI Health Care Index ETF shares in Q2 2021, an estimated $54K.
  • Alpha DNA Investment Management first reported a position in Fidelity MSCI Health Care Index ETF in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Fidelity MSCI Health Care Index ETF position peaked at $54K in Q1 2021.
  • 236 funds tracked by Wall St. Rank held Fidelity MSCI Health Care Index ETF as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.